It states that epidemiological studies indicate an increased risk of NAION during semaglutide treatment and instructs doctors to urgently refer patients who report sudden vision loss for an ophthalmological examination
Patients should be educated on recognising symptoms of low blood sugarsuch as sweating, tremor, confusion, and palpitationsand the importance of carrying fast-acting glucose
Methods: UCHDW is an Observational Model Outcomes Partnership (OMOP)-based database with EHR data from the five major medical centers of the University of California Health System (UCH)
Programs offering medical weight loss for a BMI over 30, or for people with chronic weight gain, should ideally provide: Assessment of overall health (heart, metabolism, medical history)
Brand versus compounded: what changes for the patient Brand-name Zepbound and compounded tirzepatide are discussed around the same active molecule, but they are not the same regulatory product